Bristol-Myers Squibb Co (BMY)
45.52
-0.28 -0.61%
NYSE
Apr 18, 20:00
Delayed 2m
USD
View All Key Stats
BMY Key Stats
| Income Statement | |
| Revenue (TTM) | 22.56B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 3.03 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 4.92B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 71.71% |
| Profit Margin (Quarterly) | 19.42% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 74.38B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 3.303 |
| PE Ratio (TTM) | 15.02 |
| Price to Book Value | 5.301 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 2.139B |
| Return on Equity (TTM) | Upgrade |
View All BMY News
BMY News
-
WireHeadlineTime (ET)
-
Yahoo04/19 11:02
-
Yahoo04/18 10:33
-
SA Breaking News04/17 12:59
-
Yahoo04/17 12:11
-
Yahoo04/17 10:24
-
SA Breaking News04/17 08:33
-
Business Wire04/17 08:18
-
Yahoo04/17 07:48
-
Yahoo04/16 19:00
-
Yahoo04/16 17:45
View All Events
BMY Events
| Date | Type | Description |
|---|---|---|
| 07/26/2019 10:30 EDT | Misc | Bristol-Myers Squibb Co Second Quarter Earnings Conference Call in 2019 |
| 07/26/2019 | Earnings | Bristol-Myers Squibb Co Second Quarter Earnings in 2019 Release |
| 04/25/2019 10:30 EDT | Misc | Bristol-Myers Squibb Co First Quarter Earnings Conference Call in 2019 |
| 04/25/2019 | Earnings | Bristol-Myers Squibb Co First Quarter Earnings in 2019 Release |
| 04/04/2019 | Dividends | Amount: 0.41, Declared Date: Mar 07 2019, Pay Date: May 01 2019 |
| 02/25/2019 | Misc | Bristol-Myers Squibb Co Annual Report in 2018 |
| 01/24/2019 10:30 EST | Misc | Bristol-Myers Squibb Co Fourth Quarter Earnings Conference Call in 2018 |
| 01/24/2019 | Earnings | Bristol-Myers Squibb Co Fourth Quarter Earnings in 2018 Release |
| 01/03/2019 | Dividends | Amount: 0.41, Declared Date: Dec 06 2018, Pay Date: Feb 01 2019 |
| 10/25/2018 10:30 EDT | Misc | Bristol-Myers Squibb Co Third Quarter Earnings Conference Call in 2018 |
BMY Fundamentals
Income Statement View Statement
BMY Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
BMY One Page Reports
- One Page Report Download
BMY Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 45.52 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.bms.com
- Investor Relations URL: N/A
- HQ State/Province: New York
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Equity Style: Large Cap/Value
- Next Earnings Release: Apr. 25, 2019
- Last Earnings Release: Jan. 24, 2019
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Apr. 04, 2019
- Description: Bristol-Myers Squibb Co discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is leading in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs.
BMY Excel Add-In Codes
- Name: =YCI("BMY","name")
- Description: =YCI("BMY","description")
- Sector: =YCI("BMY","sector")
- Industry: =YCI("BMY","industry")
- Est. Current Fiscal Year End: =YCI("BMY","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other BMY Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- BMY Tweets Stocktwits
Advertisement
